Polymyalgia rheumatica and risk of cerebrovascular accident: A systematic review and meta-analysis

被引:2
作者
Ungprasert, Patompong [1 ,2 ,5 ]
Srivali, Narat [3 ]
Thongprayoon, Charat [4 ]
机构
[1] Mayo Clin, Dept Internal Med, Div Rheumatol, Rochester, MN USA
[2] Mayo Clin, Dept Internal Med, Div Rheumatol, Rochester, MN USA
[3] Mayo Clin, Div Pulmonol & Crit Care Med, Rochester, MN USA
[4] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[5] Mahidol Univ, Siriraj Hosp, Div Rheumatol, Dept Med, Bangkok, Thailand
关键词
Cerebrovascular disease; epidemiology; meta-analysis; polymyalgia rheumatica; GIANT-CELL ARTERITIS; VENOUS THROMBOEMBOLISM; CARDIOVASCULAR-DISEASE; TEMPORAL ARTERITIS; STROKE; INFLAMMATION; ARTHRITIS; EVENTS; COHORT;
D O I
10.4103/0028-3886.190273
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been linked to an increased risk of cerebrovascular accident (CVA), but the data on polymyalgia rheumatica (PMR) remains unclear. Materials and Methods: We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing the risk of CVA in patients with PMR versus non-PMR controls. Pooled risk ratio and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method of DerSimonian and Laird. Results: Three retrospective cohort studies and one cross-sectional study were identified and included in the data analysis. We found a significantly elevated CVA risk in patients with PMR, with the pooled risk ratio of 1.87 (95% CI, 1.43u2.43). The statistical heterogeneity was high, with an I-2 of 91%. Conclusions: Our study demonstrated a statistically significantly increased CVA risk among patients with PMR.
引用
收藏
页码:906 / 911
页数:6
相关论文
共 32 条
[1]   Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis [J].
Ait-Oufella, Hafid ;
Sage, Andrew P. ;
Mallat, Ziad ;
Tedgui, Alain .
CIRCULATION RESEARCH, 2014, 114 (10) :1640-1660
[2]  
Angelopoulos TP, 2014, CLIN EXP RHEUMATOL, V32, P126
[3]  
[Anonymous], AM COLL RHEUM ANN SC
[4]  
[Anonymous], BR J GEN PRACT
[5]   Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus [J].
Bessant, R ;
Hingorani, A ;
Patel, L ;
MacGregor, A ;
Isenberg, DA ;
Rahman, A .
RHEUMATOLOGY, 2004, 43 (07) :924-929
[6]   Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch [J].
Blockmans, D ;
Stroobants, S ;
Maes, A ;
Mortelmans, L .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (03) :246-249
[7]   Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment [J].
Borchers, Andrea T. ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2012, 11 (6-7) :A544-A554
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[10]   Risk of vascular events in patients with polymyalgia rheumatica [J].
Hancock, Adam T. ;
Mallen, Christian D. ;
Muller, Sara ;
Belcher, John ;
Roddy, Edward ;
Helliwell, Toby ;
Hider, Samantha L. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (13) :E495-E501